Skip to main content
. 2022 Apr 7;122(6):1473–1484. doi: 10.1007/s00421-022-04939-x

Fig. 2.

Fig. 2

Boxplots for CC16 concentrations each pre- and post each trial. Plasma-CC16 (left figure) increased after both trials (p < 0.001 for both), the increase was less using a HME (p < 0.001). Urine-CC16 (right figure) also increased after both trials (p < 0.001 for both), without significant difference between trials